Chase Knickerbocker

Stock Analyst at Craig-Hallum

(1.36)
# 1790
Out of 5,370 analysts
42
Total ratings
50.00%
Success rate
13.18%
Average return
18 Stocks
Name Action PT Current % Upside Ratings Updated
NRXS Neuraxis
Initiates Coverage On: Buy
7
2.55 174.51% 1 Jun 16, 2025
PHAT Phathom Pharmaceutic...
Maintains: Strong Buy
12 17
10.6 60.38% 2 Jun 9, 2025
FENC Fennec Pharmaceutica...
Maintains: Strong Buy
12 13
8.08 60.89% 5 May 14, 2025
ETON Eton Pharmaceuticals
Maintains: Strong Buy
26 28
14.24 96.63% 6 May 14, 2025
XERS Xeris Biopharma Hold...
Maintains: Strong Buy
5 7
4.41 47.39% 1 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
39
20.58 89.5% 1 Feb 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
10 8
0.68 1076.47% 4 Jan 22, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
18 21
15.39 36.45% 2 Jan 17, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
5 6
3.25 84.62% 2 Jan 17, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
16 12
3.98 201.51% 2 Nov 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
10
3.67 172.48% 1 Nov 4, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
20 16
14.19 12.76% 3 Oct 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
45 65
31.53 106.15% 3 Oct 4, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
6 8
n/a n/a 2 Sep 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
14 12
5.98 100.67% 2 Aug 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
10
7.73 29.37% 1 Jul 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
22 23
9.48 142.62% 2 May 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
1 2
0.63 90.48% 2 Jul 11, 2023